Mechanism of inhibition of mitochondrial respiratory complex I by 6-hydroxydopamine and its prevention by desferrioxamine

被引:72
作者
Glinka, Y
Tipton, KF
Youdim, MBH
机构
[1] Technion Israel Inst Technol, Fac Med, Rappaport Family Inst Res Med Sci, Dept Pharmacol,NPF, IL-31096 Haifa, Israel
[2] Trinity Coll Dublin, Dept Biochem, Dublin, Ireland
关键词
mitochondrial respiratory complex I; 6-hydroxydopamine; inhibition; kinetic mechanism; protection by desferrioxamine;
D O I
10.1016/S0014-2999(98)00279-9
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Inhibition of mitochondrial complex I by 6-hydroxydopamine was studied in brain and liver preparations. NADH-quinone reductase activity of this complex from rat brain was inhibited by 6-hydroxydopamine partially uncompetitively with respect to NADH with a value of K-i 0.051 +/- 0.014 mM. The inhibition patterns for liver NADH-quinone reductase were more complicated than those obtained with the brain enzyme. Desferrioxamine behaved as a 'competitive' activator of complex I from both liver and brain (K-a = 2 mM and 0.02 mM, respectively). It also protected brain complex I against the inhibition by increasing K-i value about 10-fold. Furthermore, in the presence of desferrioxamine the residual activity of enzyme-substrate-inhibitor complex was increased. The data suggest that desferrioxamine does not compete directly with 6-hydroxydopamine for binding to the inhibitory site, but induces a conformation which is unfavorable for the binding of the inhibitor to the protein. The qualitative and quantitative differences between the behavior of the liver and brain enzyme complexes indicate that the assumption that the behavior of liver mitochondria can be used as a model for the situation in brain should be reconsidered. (C) 1998 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:121 / 129
页数:9
相关论文
共 17 条
[1]   THE IRON CHELATOR DESFERRIOXAMINE (DESFERAL) RETARDS 6-HYDROXYDOPAMINE-INDUCED DEGENERATION OF NIGROSTRIATAL DOPAMINE NEURONS [J].
BENSHACHAR, D ;
ESHEL, G ;
FINBERG, JPM ;
YOUDIM, MBH .
JOURNAL OF NEUROCHEMISTRY, 1991, 56 (04) :1441-1444
[2]   DOPAMINE NEUROTOXICITY - INHIBITION OF MITOCHONDRIAL RESPIRATION [J].
BENSHACHAR, D ;
ZUK, R ;
GLINKA, Y .
JOURNAL OF NEUROCHEMISTRY, 1995, 64 (02) :718-723
[3]   IRREVERSIBLE INHIBITION OF MITOCHONDRIAL COMPLEX-I BY 1-METHYL-4-PHENYLPYRIDINIUM - EVIDENCE FOR FREE-RADICAL INVOLVEMENT [J].
CLEETER, MWJ ;
COOPER, JM ;
SCHAPIRA, AHV .
JOURNAL OF NEUROCHEMISTRY, 1992, 58 (02) :786-789
[4]  
Dixon M, 1979, ENZYMES, P389
[5]   The specificity of mitochondrial complex I for ubiquinones [J].
Esposti, MD ;
Ngo, A ;
McMullen, GL ;
Ghelli, A ;
Sparla, F ;
Benelli, B ;
Ratta, M ;
Linnane, AW .
BIOCHEMICAL JOURNAL, 1996, 313 :327-334
[6]   MANGANESE AND CALCIUM EFFLUX KINETICS IN BRAIN MITOCHONDRIA - RELEVANCE TO MANGANESE TOXICITY [J].
GAVIN, CE ;
GUNTER, KK ;
GUNTER, TE .
BIOCHEMICAL JOURNAL, 1990, 266 (02) :329-334
[7]  
Glinka Y, 1996, J NEUROCHEM, V66, P2004
[8]   INHIBITION OF MITOCHONDRIAL COMPLEX-I AND COMPLEX-IV BY 6-HYDROXYDOPAMINE [J].
GLINKA, YY ;
YOUDIM, MBH .
EUROPEAN JOURNAL OF PHARMACOLOGY-ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY SECTION, 1995, 292 (3-4) :329-332
[9]   1-METHYL-4-PHENYLPYRIDINIUM (MPP+) INDUCES NADH-DEPENDENT SUPEROXIDE FORMATION AND ENHANCES NADH-DEPENDENT LIPID-PEROXIDATION IN BOVINE HEART SUBMITOCHONDRIAL PARTICLES [J].
HASEGAWA, E ;
TAKESHIGE, K ;
OISHI, T ;
MURAI, Y ;
MINAKAMI, S .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1990, 170 (03) :1049-1055
[10]  
HATEFI Y, 1979, METHODS ENZYMOLOGY P, P577